Business ❯ Healthcare ❯ Pharmaceutical Industry

Drug Development

Clinical Trials Women's Health GLP-1 Medicines Precision Medicine GLP-1 Weight-Loss Drugs Obesity Treatments Investor Relations Market Dynamics Peptide Drugs Market Competition

Wall Street Unanimously Bullish on Teva as Austedo Fuels Turnaround

Analysts say rising Austedo sales alongside Teva's move into branded drugs could lift the stock if the company sustains execution.

Stories older than 24h

Lilly’s Foundayo Start Trails Wegovy as Street Stays Positive

Ligand to Buy XOMA Royalty for $739 Million

Eli Lilly’s Q4 Beat and Bullish Outlook Give Way to Stock Drop on Low-Cost GLP-1 Pills

AbbVie Beats Q4 and Raises 2026 Outlook as Shares Fall on Aesthetics, Oncology Concerns

Eli Lilly Becomes First Health Care Company Valued at $1 Trillion

AI Pinpoints Target of New IBD Antibiotic Enterololin, Speeding Development

Berenberg Upgrades Novo Nordisk to Buy, Sets DKK425 Price Target

FDA Publishes Over 200 Complete Response Letters for 2020–24 Drug Applications

Glenmark Stock Hits Record High on $700 Million AbbVie Cancer Drug Deal

Merck to Acquire Verona Pharma in $10 Billion Deal for Ohtuvayre COPD Therapy

BioNTech Acquires China's Biotheus for $800 Million to Enhance Cancer Drug Development